Cardiovascular Biomarkers: Pathophysiology and Disease Management (Contemporary Cardiology)

Front Matter....Pages i-xvii
Front Matter....Pages 1-1
Biomarkers of Myocardial Necrosis....Pages 3-25
Analytical Issues for Clinical Use of Cardiac Troponin....Pages 27-40
Defining Myocardial Infarction....Pages 41-59
Biomarkers in the Emergency Department....Pages 61-77
Cardiac Troponin for Risk Assessment and Management of Non-ST-Elevation Acute Coronary Syndrome....Pages 79-92
Biomarkers of Necrosis for Risk Assessment and Management of ST-Elevation Myocardial Infarction....Pages 93-102
Cardiac Troponin After Revascularization Procedures....Pages 103-118
Biomarkers of Necrosis in Heart Failure....Pages 119-128
Is There a Role for Cardiac Troponin and Other Biomarkers in Patients With Pulmonary Embolism?....Pages 129-137
Cardiac Troponin in Conditions Other Than Acute Coronary Syndromes....Pages 139-159
Degradation of Cardiac Troponins....Pages 161-174
Front Matter....Pages 175-175
Developing a Marker of Ischemia....Pages 177-192
Emerging Biomarkers of Myocardial Ischemia....Pages 193-203
Front Matter....Pages 205-205
Inflammation in Cardiovascular Disease....Pages 207-221
Analytic Issues for Clinical Use of C-Reactive Protein....Pages 223-235
C-Reactive Protein as a Tool for Risk Assessment in Primary Prevention....Pages 237-260
High-Sensitivity C-Reactive Protein for Risk Assessment in Acute Coronary Syndromes....Pages 261-275
Beyond C-Reactive Protein....Pages 277-293
Biomarkers of Inflammation....Pages 295-318
Biomarkers of Infection and Risk of Coronary Heart Disease....Pages 319-344
Front Matter....Pages 345-345
Biology of Natriuretic Peptides....Pages 347-372
Analytic Issues for Clinical Use of B-Type Natriuretic Peptide and N-Terminal Pro B-Type Natriuretic Peptide....Pages 373-385
Clinical Use of Natriuretic Peptides for the Diagnosis and Management of Heart Failure....Pages 387-408
Natriuretic Peptides in Acute and Chronic Coronary Artery Disease....Pages 409-425
Novel Markers of Hemodynamic Stress....Pages 427-447
Front Matter....Pages 449-449
Clinical and Research Applications of Markers of Thrombosis....Pages 451-466
Measures of Platelet Activation and Aggregation....Pages 467-485
Monocyte-Platelet Aggregates in Patients With Ischemic Heart Disease....Pages 487-493
Front Matter....Pages 495-495
Measurement of Atherogenic Lipoproteins in Cardiovascular Risk Assessment....Pages 497-517
Lipoprotein-Associated Phospholipase A 2 and Other Lipid-Related Biomarkers in Cardiovascular Disease....Pages 519-542
Front Matter....Pages 543-543
A Multimarker Approach to Evaluation of Patients With Acute Coronary Syndrome....Pages 545-558
Cardiac Biomarkers by Point-of-Care Testing....Pages 559-574
Proteomics and Discovery of Cardiovascular Biomarkers....Pages 575-586
Genetic Markers in Cardiovascular Disease....Pages 587-608
Back Matter....Pages 609-620